Sun Life Financial’s Biogen BIIB Stock Holding History

Sun Life Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-91	Closed	-$25K	–	131
2021 Q1	$25K	Hold	91	–	–	﹤0.01%	229
2020 Q4	$22K	Sell	91 -3	-3%	-$774	﹤0.01%	234
2020 Q3	$27K	Sell	94 -14	-13%	-$3.9K	﹤0.01%	214
2020 Q2	$29K	Buy	108 +1	+0.9%	+$301	0.01%	182
2020 Q1	$34K	Sell	107 -1	-0.9%	-$303	0.01%	152
2019 Q4	$32K	Sell	108 -43	-28%	-$11.9K	0.01%	172
2019 Q3	$35K	Sell	151 -8	-5%	-$1.86K	0.01%	331
2019 Q2	$37K	Sell	159 -174	-52%	-$40.2K	0.01%	320
2019 Q1	$79K	Sell	333 -224	-40%	-$70.5K	0.02%	298
2018 Q4	$168K	Buy	557 +5	+0.9%	+$1.6K	0.04%	222
2018 Q3	$195K	Sell	552 -1,520	-73%	-$523K	0.04%	239
2018 Q2	$601K	Buy	2,072 +1,398	+207%	+$393K	0.09%	107
2018 Q1	$2.46K	Sell	674 -1,288	-66%	-$400K	0.02%	191
2017 Q4	$625K	Sell	1,962 -1,101	-36%	-$353K	0.06%	103
2017 Q3	$959K	Buy	3,063 +29	+1%	+$8.59K	0.09%	79
2017 Q2	$823K	Buy	3,034 +2,592	+586%	+$685K	0.09%	83
2017 Q1	$1.62K	Buy	+442	New	+$125K	﹤0.01%	120

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sun Life Financial's BIIB Position: Q2 2021 in Review

Sun Life Financial sold out of Biogen (BIIB) in Q2 2021, closing a stake of 91 shares — an estimated $25K sold.

Sun Life Financial first reported a position in BIIB in Q1 2017 and held it in 17 quarters. The position peaked at $959K in Q3 2017. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Sun Life Financial reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Sun Life Financial sold 91 Biogen shares in Q2 2021, an estimated $25K.
Sun Life Financial first reported a position in Biogen in Q1 2017 and held it in 17 quarters.
Sun Life Financial's Biogen position peaked at $959K in Q3 2017.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.